Dudediligence.

Biohaven Ltd

BHVNNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$160.3MSep ’24−$186.8MDec ’24−$221.7MMar ’25−$198.1MJun ’25−$173.4MSep ’25−$145.6MDec ’25−$130.5MMar ’26−$137.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$218.9M−$567.9M−$436.1M−$885.1M−$745.4M
Net income−$213.8M−$570.3M−$408.2M−$846.4M−$738.8M
Operating cash flow−$145.8M−$297.7M−$331.7M−$582.5M−$609.4M
Free cash flow−$146.8M−$303.8M−$334.8M−$586.5M−$610.2M
Cash$76.1M$204.9M$248.4M$99.1M$230.0M
Shares outstanding068.2M81.1M101.2M132.8M